Metropolitan Life Insurance Company (MetLife)’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-16,655
| Closed | -$1.33M | – | 2945 |
|
|
2021
Q1 | $1.33M | Sell |
16,655
-54
| -0.3% | -$4.22K | 0.02% | 761 |
|
|
2020
Q4 | $1.32M | Sell |
16,709
-1,158
| -6% | -$67.9K | 0.02% | 700 |
|
|
2020
Q3 | $785K | Sell |
17,867
-282
| -2% | -$13.9K | 0.01% | 891 |
|
|
2020
Q2 | $803K | Buy |
18,149
+7,184
| +66% | +$268K | 0.01% | 873 |
|
|
2020
Q1 | $394K | Sell |
10,965
-589
| -5% | -$33.5K | 0.01% | 1192 |
|
|
2019
Q4 | $819K | Buy |
11,554
+253
| +2% | +$18.4K | 0.01% | 1021 |
|
|
2019
Q3 | $845K | Sell |
11,301
-919
| -8% | -$77.9K | 0.01% | 957 |
|
|
2019
Q2 | $985K | Sell |
12,220
-50
| -0.4% | -$3.52K | 0.02% | 905 |
|
|
2019
Q1 | $821K | Sell |
12,270
-61
| -0.5% | -$4.62K | 0.01% | 988 |
|
|
2018
Q4 | $918K | Buy |
12,331
+19
| +0.2% | +$1.57K | 0.02% | 853 |
|
|
2018
Q3 | $1.13M | Buy |
12,312
+142
| +1% | +$13.5K | 0.02% | 867 |
|
|
2018
Q2 | $1.2M | Sell |
12,170
-8,611
| -41% | -$963K | 0.02% | 828 |
|
|
2018
Q1 | $2.32M | Buy |
20,781
+9,422
| +83% | +$1.06M | 0.03% | 443 |
|
|
2017
Q4 | $1.17M | Sell |
11,359
-13,020
| -53% | -$1.3M | 0.02% | 818 |
|
|
2017
Q3 | $2.3M | Sell |
24,379
-178
| -0.7% | -$14K | 0.01% | 896 |
|
|
2017
Q2 | $1.91M | Hold |
24,557
| – | – | 0.01% | 962 |
|
|
2017
Q1 | $1.97M | Hold |
24,557
| – | – | 0.01% | 963 |
|
|
2016
Q4 | $1.93M | Sell |
24,557
-421
| -2% | -$32.7K | 0.01% | 982 |
|
|
2016
Q3 | $1.95M | Sell |
24,978
-394
| -2% | -$28.6K | 0.01% | 966 |
|
|
2016
Q2 | $1.74M | Buy |
25,372
+499
| +2% | +$34.4K | 0.01% | 992 |
|
|
2016
Q1 | $1.77M | Buy |
24,873
+235
| +1% | +$14.8K | 0.01% | 934 |
|
|
2015
Q4 | $1.53M | Sell |
24,638
-215
| -0.9% | -$13.1K | 0.01% | 992 |
|
|
2015
Q3 | $1.41M | Sell |
24,853
-316
| -1% | -$16.7K | 0.01% | 1034 |
|
|
2015
Q2 | $1.35M | Sell |
25,169
-969
| -4% | -$47.1K | 0.01% | 1120 |
|
|
2015
Q1 | $1.24M | Sell |
26,138
-1,194
| -4% | -$52.9K | 0.01% | 1087 |
|
|
2014
Q4 | $1.18M | Buy |
27,332
+1,029
| +4% | +$42K | 0.01% | 1224 |
|
|
2014
Q3 | $904K | Sell |
26,303
-2
| -0% | -$71 | 0.01% | 1346 |
|
|
2014
Q2 | $963K | Hold |
26,305
| – | – | 0.01% | 1375 |
|
|
2014
Q1 | $887K | Hold |
26,305
| – | – | 0.01% | 1433 |
|
|
2013
Q4 | $892K | Buy |
26,305
+1,327
| +5% | +$46K | 0.01% | 1402 |
|
|
2013
Q3 | $796K | Sell |
24,978
-1,313
| -5% | -$34.9K | 0.01% | 1434 |
|
|
2013
Q2 | $594K | Buy |
+26,291
| New | +$569K | ﹤0.01% | 1584 |
|
Metropolitan Life Insurance Company (MetLife)'s CMD Position: Q2 2021 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 16,655 shares — an estimated $1.33M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $2.32M in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 16,655 Cantel Medical Corporation shares in Q2 2021, an estimated $1.33M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Cantel Medical Corporation position peaked at $2.32M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2021, filed 16 Aug 2021.